抗菌化合物对抗非生长和细胞内细菌
Niilo Kaldalu1, Normunds Bērziņš2, Stina Berglund Fick3
1Institute of Technology, University of Tartu, Tartu, Estonia. niilo.kaldalu@ut.ee.
npj antimicrobials and resistance
|April 11, 2025
概括
研究人员对6454种药物进行了选,以寻找对导致持续感染的不生长细菌的治疗方法. 他们确定了39种化合物,包括重新定制的药物,有效对抗像大肠杆菌这样的生长缓慢的细菌.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 传染性疾病 传染性疾病
背景情况:
- 缓慢和不增长的细菌,包括细胞内病原体,很难用标准抗生素治疗,导致持久和复发性感染.
- 对于专门针对这些非增殖细菌群体的新型疗法有着至关重要的需求.
研究的目的:
- 确定有效对抗非生长性尿路病原菌大肠杆菌 (UPEC) 的现有药物.
- 评估这些已识别的化合物的治疗持久性细菌感染的潜力.
主要方法:
- 对6454种已批准的药物和候选药物进行了药物再利用选.
- 稀释复生试验用于识别杀死或延迟非生长UPEC的复生化合物.
- 进一步对非生长的Pseudomonas aeruginosa和Staphylococcus aureus进行了测试,并评估了它们抑制细胞内Shigella flexneri的能力.
主要成果:
- 鉴定出39种化合物对非生长的UPEC有活性,包括诺基诺,化物,利法胺素和抗癌剂. 其中29种前所未知对抗不生长细菌的活性.
- 十种化合物表现出强烈的杀菌活性,对非生长的P. aeruginosa.
- 四种化合物 (沙利特罗米,瓦尔尼穆林,埃沃胺和萨特拉普拉丁) 选择性地向不生长的细菌,对生长的细菌的疗效较差.
- 31个命中化合物抑制了细胞内Shigella flexneri,表明宿主细胞透.
结论:
- 该研究确定了大量现有药物,它们对不生长的细菌具有潜在活性.
- 这些化合物,特别是那些对非生长形式具有选择性活性的化合物,有望开发针对持久和复发性感染的新疗法.
- 需要进一步的比较研究来评估这些化合物与当前的标准治疗抗生素相比.
更多相关视频
相关概念视频
Antimicrobial Proteins
745
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
745
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Surface Membrane Barriers
687
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
687
Antibiotic Selection
52.0K
Overview
52.0K
Defense Against Bacterial Pathogens
1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K


